Global Trust Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Sell
1,449
-1,036
-42% -$137K 0.06% 149
2026
Q1
$346K Sell
2,485
-169
-6% -$23.7K 0.13% 95
2025
Q4
$326K Buy
2,654
+454
+21% +$55.2K 0.13% 104
2025
Q3
$244K Buy
2,200
+430
+24% +$48.9K 0.11% 150
2025
Q2
$196K Buy
+1,770
New +$188K 0.1% 155
2023
Q2
Sell
-631
Closed -$52.4K 453
2023
Q1
$52.4K Hold
631
0.03% 228
2022
Q4
$54.2K Sell
631
-78
-11% -$6.18K 0.03% 219
2022
Q3
$44K Buy
709
+78
+12% +$4.92K 0.02% 226
2022
Q2
$39K Sell
631
-156
-20% -$9.66K 0.02% 243
2022
Q1
$47K Hold
787
0.02% 280
2021
Q4
$57K Sell
787
-509
-39% -$35.1K 0.02% 251
2021
Q3
$91K Hold
1,296
0.04% 211
2021
Q2
$89K Sell
1,296
-233
-15% -$15.6K 0.04% 223
2021
Q1
$99K Sell
1,529
-5,573
-78% -$359K 0.05% 193
2020
Q4
$414K Sell
7,102
-413
-5% -$24.9K 0.23% 107
2020
Q3
$476K Hold
7,515
0.3% 86
2020
Q2
$578K Sell
7,515
-8,399
-53% -$644K 0.4% 68
2020
Q1
$1.21M Buy
15,914
+8,194
+106% +$566K 0.94% 22
2019
Q4
$502K Sell
7,720
-967
-11% -$63K 0.3% 101
2019
Q3
$551K Sell
8,687
-439
-5% -$28.7K 0.37% 86
2019
Q2
$617K Sell
9,126
-286
-3% -$18.8K 0.41% 78
2019
Q1
$612K Sell
9,412
-420
-4% -$27.9K 0.45% 73
2018
Q4
$615K Sell
9,832
-830
-8% -$58K 0.55% 54
2018
Q3
$823K Sell
10,662
-1,678
-14% -$127K 0.57% 47
2018
Q2
$874K Sell
12,340
-60
-0.5% -$4.24K 0.66% 42
2018
Q1
$935K Sell
12,400
-125
-1% -$9.94K 0.74% 36
2017
Q4
$897K Buy
+12,525
New +$951K 0.64% 44

Other funds holding GILD

Global Trust Asset Management's GILD Position: Q2 2026 in Review

Global Trust Asset Management reduced its Gilead Sciences (GILD) stake by 42% in Q2 2026, selling an estimated $137K and leaving 1,449 shares worth $183K. The position accounts for 0.06% of the portfolio, ranked #149.

Global Trust Asset Management first reported a position in GILD in Q4 2017 and has held it in 27 quarters since. The position peaked at $1.21M in Q1 2020. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Global Trust Asset Management held 1,449 shares of Gilead Sciences worth $183K as of Q2 2026.
  • Global Trust Asset Management sold 1,036 Gilead Sciences shares in Q2 2026, an estimated $137K.
  • Gilead Sciences made up 0.06% of Global Trust Asset Management's portfolio in Q2 2026, its #149 holding.
  • Global Trust Asset Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 27 quarters since.
  • Global Trust Asset Management's Gilead Sciences position peaked at $1.21M in Q1 2020.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.